Does HYDROCHLOROTHIAZIDE\VALSARTAN Cause Bladder transitional cell carcinoma? 32 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Bladder transitional cell carcinoma have been filed in association with HYDROCHLOROTHIAZIDE\VALSARTAN. This represents 0.5% of all adverse event reports for HYDROCHLOROTHIAZIDE\VALSARTAN.
32
Reports of Bladder transitional cell carcinoma with HYDROCHLOROTHIAZIDE\VALSARTAN
0.5%
of all HYDROCHLOROTHIAZIDE\VALSARTAN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From HYDROCHLOROTHIAZIDE\VALSARTAN?
Of the 32 reports, 26 (81.3%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE\VALSARTAN. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does HYDROCHLOROTHIAZIDE\VALSARTAN Cause?
Blood pressure increased (645)
Drug ineffective (493)
Dizziness (467)
Malaise (446)
Hypertension (408)
Headache (384)
Fatigue (353)
Dyspnoea (309)
Fall (293)
Nausea (279)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which HYDROCHLOROTHIAZIDE\VALSARTAN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
HYDROCHLOROTHIAZIDE\VALSARTAN vs HYDROCODONE
HYDROCHLOROTHIAZIDE\VALSARTAN vs HYDROCODONE/ACETAMINOPHEN
HYDROCHLOROTHIAZIDE\VALSARTAN vs HYDROCODONE\IBUPROFEN
HYDROCHLOROTHIAZIDE\VALSARTAN vs HYDROCODONE+PARACETAMOL
HYDROCHLOROTHIAZIDE\VALSARTAN vs HYDROCORTISONE